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Maitotoxin (MTX), a potent marine toxin, elicits a calcium-dependent ac ivation of cells that can be inhibited by calcium 
channel blockers like nifedipine. MTX also stimulates phosphoinositide br akdown i smooth muscle cells, NCB-20 cells 
and PC 12 cells through anifedipine-insensitive m chanism. We now report hat MTX stimulates phosphoinositide br ak- 
down in a wide variety of ceils, and appears to repesent the first general activator of this second messenger-generating 
system. MTX-induced stimulation ofphosphoinositide br akdown is dependent inevery cell line on the presence of extra- 
cellular calcium. In differentiated HL60 cells, in which a chemotactic peptide (fMLP) activates phosphoinositide br ak- 
down via a pertussis toxin-sensitive mechanism, MTX-induced stimulation isnot affected by pertussis toxin treatment. 
A phorbol ester has no effect on the response to MTX. Thus, MTX stimulates phosphoinositide breakdown through 
a calcium-dependent mechanism that at least in three cell lines (PC12, NCB20 and HL60) is not mediated by a pathway 
that involves apertussis toxin-sensitive guanine nucleotide-binding protein. 
Maitotoxin; Phosphoinositide breakdown; Ca 2+ channel 
1. INTRODUCTION 
Mai totox in  (MTX),  isolated f rom the dino- 
f lagel late Gambierdiscus toxicus [1], elicits the 
release o f  neurotransmitters and hormones f rom 
secretory cells [2-5],  st imulates the uptake of  
calc ium [1,2,4-7] and induces the contract ion of  
smooth  muscle and cardiac tissue [6,8,9]. In every 
case, the effects o f  MTX are dependent on the 
presence o f  extracel lular calcium. In most cells 
calc ium channel blockers inhibit the effects of  
MTX [1,6] and it has been proposed that MTX is 
a direct act ivator  o f  vol tage-dependent calcium 
channels [1]. 
At  lower concentrat ions than those required to 
elicit calcium channel act ivat ion, MTX elicits 
phosphoinos i t ide breakdown in rat aort ic myo-  
cytes [ 10], neurob lastoma hybr id NCB-20 cells [ 11] 
and pheochromocytoma PC12 ceils [12]. St imula- 
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t ion o f  phosphoinos i t ide breakdown by MTX 
depends on the presence of  extracel lular calcium 
[11]. However,  in contrast  o the effects o f  MTX 
on voltage-dependent calcium channels, the st imu- 
lat ion of  phosphoinos i t ide breakdown by MTX is 
not  af fected by a variety of  organic and inorganic 
b lockers of  calcium channels [10-12]. 
We now show that MTX st imulates the break-  
down of  phosphoinosi t ides in a wide variety of  
cells and in brain synaptoneurosomes,  a  assessed 
by the accumulat ion of  [3H]inositol mono- ,  bis- 
and tr isphosphates.  The response is insensitive to 
pertussis toxin or phorbo l  esters. 
2. MATERIALS  AND METHODS 
2.1. Cells 
Cells were generously provided as follows: NCB-20, Dr D.M. 
Chuang (NIMH, Washington, DC); C6 rat glioma, Dr P. 
Fishman (NINCDS, Bethesda, MD); P2E rabbit kidney cell 
line, Dr L. Arendt (Michigan State University, East Lansing, 
MI); L fibroblasts, Dr P. Torrence (NIDDK, Bethesda); 
RBL2H3, Dr M. Beaven (NHLBI, Bethesda); PC12 pheo- 
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Table 1 
Maitotoxin (MTX)-induced stimulation of phosphoinositide breakdown in cultured cell 
lines and guinea pig synaptoneurosomes 
Cell or tissue [Ca 2+] 
(mM) 
cpm/10000 cpm in lipids 
[3H]IPI [3H]IP2 [3H]IP3 
NCB-20 neuroblastoma hybrid 
Control 
MTX 
C6 rat glioma cells 
Control 
MTX 
P2E kidney cells 
Control 
MTX 
4.5 
4.5 
4.5 
L fibroblasts 1.5 
Control 
MTX 
RBL2H3 basophils 4.5 
Control 
MTX 
PCI2 pheochromocytoma cells 
Control 
MTX 
HL60 human leukemic ells 
Control 
MTX 
Mouse pituitary cells 
Control 
MTX 
Guinea pig synaptoneurosomes 
Control 
MTX 
1.5 
1.5 
1.5 
280+ 95 50-+ 15 120-+ 50 
2160 :l: 200 280 -+ 60 300 -+ 50 
(780070) (590070) (25007o) 
290+ 160 90-+ I0 130+ 20 
2820 -+ 470 350 -+ 50 300 -+ 20 
(980%) (410070) (230070) 
710_+ 110 110 + 10 140+ 10 
1600± 140 280+ 40 280_+ 20 
(220070) (250070) (200070) 
1420 -+ 80 260 + 60 270 -+ 60 
4350 _+ 620 1100 -+ 200 1290 + 200 
(310070) (430°70) (480%) 
600-+100 140-+ 30 200-+ 20 
1230 -+ 340 170 -+ 5 200 -+ 5 
(200070) (120070) (100070) 
330+ 50 40_+ 5 60_+ 5 
1660+ 5 190+ 30 160+ 20 
(510070) (450070) (260070) 
960_+ 60 170_+ 30 230+ 30 
3350 -+ 340 1120 + 100 310 -+ 20 
(350070) (670°70) (130°7o) 
260 + 40 80,80 470,380 
770 _+ 150 1080,310 710,340 
(30O070) 
720 _+ 80 
1300 + 250 
(180070) 
Cells were labelled with [3H]inositol (10/zCi/ml) for 12-16 h in multiwell plates (36 h for 
HL60 cells), while synaptoneurosomes w re labelled for 60 min (see [15] for details). After 
washing, cells or synaptoneurosomes were exposed to MTX (0.5 ng/ml) for 30 min at 
37°C. Incubations were stopped by aspirating the buffer and adding 1 ml of 607o 
trichloroacetic acid. [3H]lnositol phosphates were anayzed by anion-exchange 
chromatography asdescribed [15]. For HL60 cells the method of Brandt et al. [14] was 
followed. The Ca 2+ concentration was that which allowed for maximal stimulation of 
phosphoinositide breakdown in each cell. Values in parentheses are percent of respective 
control 
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chromocytoma, Dr G. Guroff (NINCDS, Bethesda); HL60, Dr 
J. Gutkind (NIDR, Bethesda); mouse anterior pituitary primary 
cultures, Dr M.G. Castro (NICHD, Bethesda). 
2.2. Cell culture 
Culture media for cells were as follows: NCB-20 and L 
fibroblasts, Dulbecco's modified Eagle's medium (DMEM) 
with 10070 fetal calf serum (FCS) and penicillin (100 U/ml) and 
streptomycin (100/~g/ml); C6 rat glioma cells, DMEM with 5070 
FCS; P2E cells, DMEM with 10070 FCS and 1 ,aM dexame- 
thasone; RBL2H3, Eagle's medium with Earle's salts and with 
15070 FCS; PCI2 cells, DMEM with 6070 fetal calf serum, 6070 
horse serum and penicillin (100U/ml) and streptomycin 
(100/~g/ml); HL60 cells, RPMI 1640 with 10070 FCS; mouse 
anterior pituitary cells, DMEM with 10070 FCS. 
2.3. Phosphoinositide breakdown 
Experiments in NCB-20, C6 glioma, P2E cells, L fibroblasts, 
RBL2H3, PC 12 cells and mouse anterior pituitary cultures were 
determined as described [11]. Briefly, on the day before the ex- 
periment, cells were transferred from 150-cm 2 culture flasks 
and subcultured in 12-well dishes with medium containing 
10/~Ci/ml [3H]inositol (14-17 Ci/mmoi). [3H]Inositol-labelled 
cells were washed twice with buffer A (118 mM NaC1, 4.7 mM 
KCI, 3 mM CaC12, 1.2 mM MgSO4, 1.2 mM KH2PO4, 0.5 mM 
EDTA, 10 mM glucose, 20 mM Hepes; pH 7.4). Cells were 
then incubated in buffer A, containing 60 mM LiCI (osmolarity 
maintained by reducing NaCI to 58 mM), for 20 rain. Agents 
were then added and incubations continued for 30 min at 37°C. 
Cells were scraped from the plates and transferred to 1.5-ml 
microfuge tubes. After centrifugation for 1 min the supernatant 
was discarded and 1 ml of 6070 trichloroacetic a id was added. 
The tubes were vortex-mixed, centrifuged for 1.5 min and the 
supernatant was applied to anion-exchange columns (Bio Rad 
AG IXS, 100-200 mesh, formate form). Separation and elution 
of [3H]inositol phosphates by anion-exchange chromatography 
was performed as described by Berridge et al. [13]. For HL60 
cells, the labeling, washing and phosphoinositide breakdown 
procedure was as described by Brandt et al. [14]. For guinea pig 
synaptonenrosomes our described procedure was followed [15]. 
2.4. Materials 
Maitotoxin was purified to homogeneity from G. toxicus as 
in [1]. [3H]Inositol (12-17 Ci/mmol) was obtained from Du- 
pont, NEN (Boston, MA); pertussis toxin (IAP) from List 
Biological (Campbell, CA); formylmethionylleucylphenyl- 
alanine (fMLP) and phorbol 12-myristate 13-acetate (PMA) 
from Sigma (St. Louis, MO); ionomycin and A23187 from 
Calbiochem (La Jolla, CA); and culture media and sera from 
Gibco (Grand Island, NY). 
3. RESULTS 
In every cell line and in synaptoneurosomes, 
MTX-elicited stimulation of phosphoinositide 
breakdown is eliminated when the incubation 
medium lacks calcium ([11,12] and not shown). 
Results were similar in media containing 10 mM 
LiCl (not shown). MTX-elicited stimulation of 
phosphoinositide breakdown increases with in- 
creasing extracellular calcium concentrations ([12] 
and not shown). The requirement of calcium for 
MTX action varies from cell to cell ([12] and not 
shown). There seem to be two different groups in 
terms of calcium threshold for MTX activity. In 
one group (PC12, P2E, L fibroblasts, RBL, HL60 
and mouse pituitary), MTX stimulation of phos- 
phoinositide breakdown can be observed at cal- 
cium concentrations as low as 50-100/LM. In the 
other group (NCB20, C6, synaptoneurosomes) 
MTX action can only be detected at calcium con- 
centrations of 1-1.5 mM and higher. As previous- 
ly noted for NCB-20 and PC12 cells [12], the 
concentration of extracellular calcium at which 
maximal MTX-elicited stimulation of phosphoino- 
sitide breakdown occurs differs markedly in diffe- 
rent cell lines: The percent stimulation of 
formation of [3H]inositol phosphates listed in table 
1 corresponds in each case to the maximal stimula- 
tion by MTX at the calcium concentration that is 
optimal for each cell line. In most cell lines calcium 
concentrations ___9 mM result in a reduction of 
MTX-stimulated phosphoinositide breakdown 
(not shown). But in a rat glioma cell line ((26) and 
NCB-20 
1000 
800 
600 
HL-60  
o 
cz 
400 
200 
Fig.l. Effect of combination of maitotoxin and receptor 
agonists on phosphoinositide breakdown. NCB-20 cells 
differentiated with sodium butyrate for 3 days and HL60 cells 
differentiated with dibutyryl cyclic AMP for 36 h were labelled 
with [3H]inositol as described [14]. Cells then were washed and 
incubated with carbamylcholine (CaCh, 1 mM), maitotoxin 
(MTX, 0.5 ng/ml), or fMLP (1/~M) alone or in combination 
for 30 min. [3H]Inositol monophosphate was analyzed as in 
[14]. Values are from three or more experiments performed in 
triplicate. Values are expressed as percent of respective 
controls. 
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in guinea pig cerebral cortical synaptoneurosomes 
no reduction of MTX-mediated stimulation of 
phosphoinositide breakdown occurs even with 
9.5 mM calcium. The calcium ionophores iono- 
mycin (1/~M) and A23187 (1/~M) have no or 
minimal effects on [3Hlinositol phosphate forma- 
tion in NCB-20 or PC12 cells (not shown), while 
Table 2 
Effects of pertussis toxin and phorbol esters on 
phosphoinositide breakdown 
(A) Effects of pretreatment with pertussis toxin on MTX and 
fMLP stimulation of phosphoinositide br akdown i HL60 
cells a 
Saline Pertussis toxin 
(cpm in [3Hlinositol 
monophosphate fraction) 
Control 930 + 70 770 _+ 110 
fMLP (1 #M) 3130 _+ 230 1660 + 430 
(340°70) (220070) 
MTX (0.5 ng/ml) 3650 + 310 3470 + 410 
(390070) (450070) 
(B) Lack of effect of pertussis toxin and phorbol diacetate on 
MTX-induced stimulation of phosphoinositide breakdown 
in NCB-20, PC12 and C6 cells b 
Pertussis Phorbol 
toxin c diacetate d 
(070 of response toMTX alone) 
NCB-20 neuroblastoma 
hybrid 100 120,90 
PC12 pheochromocytoma 90 100 
C6 glioma 90 ND 
" HL60 cells were differentiated and labelled with [3H]inositol 
as described [14]. Cells were pretreated with saline or pertussis 
toxin (100 ng/ml) for 2 h at 37°C. Cells were then washed 
and treated with fMLP or MTX as indicated for 30 min at 
37°C and [3H]inositol phosphates were analyzed as in [14]. 
Results are averages of three experiments performed in 
triplicate. Values in parentheses are percent of respective 
control 
b Cells were labelled with [aH]inositol for 14-16 h. After 
washing cells were incubated with MTX (0.5 ng/ml) for 
30rain and [3H]inositol phosphates were analyzed as 
described [14]. Results are expressed as percentage of
response obtained in the absence of pertussis toxin 
pretreatment or incubation with phorbol diacetate. Values are 
from single xperiments performed intriplicate 
c Pertussis toxin (100 ng/ml) was present during the 14-16 h 
labeling with laH]inositol 
d Phorbol diacetate (1/~M) was present during incubation with 
MTX 
MTX elicits about 8- and 5-fold stimulation in 
these two cell lines, respectively (table 1). 
Combination of carbamylcholine with MTX in 
differentiated NCB-20 cells or of fMLP with MTX 
in differentiated HL60 cells results in formations 
of [3H]inositol phosphates that are additive or 
somewhat less than additive, respectively, to the 
responses obtained with MTX and receptor ago- 
nists alone (fig. 1). 
Pretreatment with pertussis toxin reduces 
fMLP-mediated stimulation by about 50o7o, but 
has no effect on MTX-elicited stimulation of 
phosphoinositide breakdown in differentiated 
HL60 cells (table 2). Pertussis toxin-pretreatment 
also does not affect significantly MTX-elicited 
phosphoinositide breakdown in NCB-20 or PC12 
cells (table 2). A protein kinase C activator, phor- 
bol diacetate, which in some systems can inhibit 
receptor-mediated (see [16]) and NaF-mediated 
[17] stimulation of phosphoinositide breakdown, 
does not affect MTX-elicited stimulation in 
NCB-20 or PC12 cells (table 2). 
4. DISCUSSION 
MTX appears to be a general activator of 
phosphoinositide breakdown having elicited a 
marked calcium-dependent accumulation of 
[3H]inositol phosphates in all cell lines as yet 
studied (table 1). Both the threshold concentration 
of calcium at which MTX first elicits accumulation 
of [3H]inositol phosphates ( ee section 3) and the 
concentration of calcium at which a maximal 
response to maitotoxin occurs (table 1) differ in 
different cell lines. In every cell studied, the 
absence of extracellular calcium eliminates MTX 
responses. 
In the differentiated NCB-20 cells, muscarinic 
stimulation of phosphoinositide breakdown occurs 
in the absence of extracellular calcium, whereas 
MTX stimulated measurable formation of [3H]- 
inositol phosphates only at calcium concentrations 
_> 1.5 mM (not shown). Thus, extracellular cal- 
cium is a requirement for MTX-mediated, but not 
receptor-mediated responses. In this cell line, 
however, the calcium ionophores ionomycin and 
A23187 (1/~M) cause only a slight increase in 
[3H]inositol phosphate formation (not shown) at 
the calcium concentration at which MTX induces 
the response indicated in table 1. Thus, MTX 
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clearly must act in a manner different from 
calcium ionophores. Previous data on calcium in- 
flux in liposomes indicated no ionophore activity 
for MTX [18]. 
Calcium could be required for MTX binding to 
an effector site, or alternatively, MTX-elicited 
stimulation of phosphoinositide breakdown could 
be elicited through a calcium uptake mechanism 
that is activated by MTX. If so, such an uptake 
mechanism must be present in all cells as yet 
studied, and must be insensitive to blockade by 
calcium channel blockers as shown in studies with 
NCB-20, PC12 cells and aortic myocytes [10-12. 
NCB-20 cells after treatment with sodium 
butyrate xpress a muscarinic receptor coupled to 
phospholipase C [19l. The HL60 human leukemic 
cells after differentiation with dibutyryl cyclic 
AMP express achemotactic peptide (fMLP) recep- 
tor coupled to phospholipase C [14,20]. Since com- 
binations of MTX with the receptor agonists in 
these cells result in responses that are larger than 
those induced by MTX or agonists alone (fig.l), 
different mechanisms for the action by MTX and 
the receptor agonists appear likely. 
Inhibition of fMLP stimulation of phosphoino- 
sitide breakdown by pertussis toxin indicates that 
a pertussis toxin-sensitive guanine nucleotide- 
binding protein mediates between fMLP receptor 
and phospholipase C activation in HL60 cells 
([14], see also [16]). The lack of effect of pertussis 
toxin on responses to MTX in HL60 and other cells 
(table 2) suggests that MTX-elicited stimulation of 
phosphoinositide breakdown is not mediated by a 
receptor coupled to a guanine nucleotide-binding 
protein, although it is conceivable that a different 
G-protein insensitive to pertussis toxin might be in- 
volved in MTX-elicited responses. 
Inhibition of receptor-mediated phosphoino- 
sitide breakdown by phorbol esters has been pro- 
posed to be mediated through phosphorylation f 
guanine nucleotide-binding proteins by protein 
kinase C [17,21]. The lack of effect of phorbol 
esters on MTX-elicited stimulation of phosphoino- 
sitide breakdown (table 2), again in contrast to in- 
hibition of receptor-mediated responses by 
phorbol esters, provides further evidence for a dif- 
ferent transduction mechanism for responses to 
MTX. 
The possibility that MTX could directly activate 
a guanine nucleotide-binding protein involved in 
signal transduction to phospholipase C seems 
unlikely. Thus, guanine nucleotide-binding pro- 
teins involved in phospholipase C activation seem 
to differ between cells; in some systems they are 
pertussis toxin-sensitive and in others they are not. 
Since MTX is a general activator for generation of 
inositol phosphates in all cells as yet tested, then 
one would have to postulate MTX to be a general 
activator of both pertussis toxin-sensitive and 
-insensitive guanine nucleotide-binding proteins. 
MTX does not affect directly other guanine 
nucleotide-binding protein-mediated phenomena, 
like stimulation or inhibition of adenylate cyclase 
(not shown). Thus, MTX is not a general activator 
of the guanine nucleotide-binding proteins. 
It appears probable that activation of phospho- 
lipase C by MTX occurs either directly or by 
making calcium readily available for enzyme acti- 
vation. If the latter is true, then MTX must in- 
teract with an as yet undescribed calcium uptake 
mechanism, which is present in most cells and is in 
every case closely related to phospholipase C func- 
tion. A distinction between these two mechanisms, 
direct activation of phospholipase C or stimulation 
of a calcium uptake system closely associated with 
phospholipase C by MTX, cannot be made as yet. 
The very high potency of MTX (ECso 150 pM), the 
stimulation by MTX of phosphoinositide break- 
down in cells in which calcium ionophores have 
marginal effects (see section 3) and the lack of 
calcium ionophore activity for MTX in liposomes 
[18], all indicate that MTX does not stimulate 
phospholipase C simply by acting as a calcium 
ionophore. 
MTX elicits increases in intracellular calcium 
that appear in PC12 and NCB-20 cells to parallel 
stimulation of inositol 1,4,5-trisphosphate forma- 
tion [12]. MTX also has effects on cyclic AMP ac- 
cumulation elicited by receptor agonists or 
forskolin that parallel those seen with phorbol 
esters in PC12 and NCB-20 cells [12]; i.e. both 
MTX and phorbol esters enhance forskolin- 
stimulated accumulation of cyclic AMP in PC12 
cells and both inhibit prostaglandin E2-stimulated 
accumulation f cyclic AMP in NCB-20 cells [12], 
probably in both cases through activation of pro- 
tein kinase C by diacylglycerides generated during 
phosphoinositide breakdown. Thus, MTX, like 
receptors coupled to phospholipase C, generates 
functionally active second messengers; i.e., 
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inositol  1,4,5-tr isphosphate and diacylglycerides; 
the inositol  t r isphoshate then promotes release of  
calc ium from intracel lular stores, while diacyl- 
glycerides then st imulate protein kinase C. 
In conclusion, MTX appears to be a general and 
useful act ivator o f  the phosphol ipase C involved in 
phosphoinos i t ide breakdown.  The use of  MTX 
al lows investigation of  effects of  phosphoinos i t ide 
breakdown in cells that  possess no known recep- 
tors coupled to phosphol ipase C. Such a general 
act ivator  also allows for the investigation of  possi- 
ble receptor-mediated inhibitory inputs to phos- 
phol ipase C. 
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